| ARTICLE |
|
|
|
|
|
| Year : 2000 | Volume
: 42
| Issue : 2 | Page : 195-197 |
Rave Drug (Ecstasy) and Selective Serotonin Reuptake Inhibitor Anti-Depressants
AN Singh1, J Catalan2
1 Consultant Psychiatrist, South Lincolnshire Healthcare NHS Trust, Beaconfield Centre, Beacon Lane, Grantham Lines, NG319DF, United Kingdom
2 Reader in Psychiatry, Imperial College School of Medicine, Channg Cross & Westminster Campus, Psychological Medicine Unit, South Kensington & Chelsea's Mental Health Centre, 1 Nightingal Palace London, SW109NG, United Kingdom
Correspondence Address:
A N Singh
Consultant Psychiatrist, South Lincolnshire Healthcare NHS Trust, Beaconfield Centre, Beacon Lane, Grantham Lines, NG319DF
United Kingdom
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 21407935 
3, 4 Methylenedioxymethamphetamine (MDMA) also known as Ecstasy is a common recreational drug of abuse and reports of abuse of tricyclic antidepressants are also known. We report two cases of misuse of selective serotonin re-uptake inhibitors (SSRIs) antidepressants in combination with Ecstasy and their beneficial subjective effects experienced by misusers. We hypothesise the probable underlying pharmacological reasons and recommend its use in the treatment of neurotoxic effects of MDMA.
[PDF]*
|
